Goldman Sachs’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $144M | Buy |
|
|||||
|
2021
Q1 | $101M | Sell |
|
|||||
|
2020
Q4 | $120M | Sell |
|
|||||
|
2020
Q3 | $170M | Buy |
|
|||||
|
2020
Q2 | $145M | Sell |
|
|||||
|
2020
Q1 | $119M | Sell |
|
|||||
|
2019
Q4 | $334M | Buy |
|
|||||
|
2019
Q3 | $245M | Buy |
|
|||||
|
2019
Q2 | $286M | Buy |
|
|||||
|
2019
Q1 | $202M | Sell |
|
|||||
|
2018
Q4 | $160M | Sell |
|
|||||
|
2018
Q3 | $291M | Sell |
|
|||||
|
2018
Q2 | $302M | Sell |
|
|||||
|
2018
Q1 | $275M | Sell |
|
|||||
|
2017
Q4 | $496M | Buy |
|
|||||
|
2017
Q3 | $485M | Sell |
|
|||||
|
2017
Q2 | $584M | Buy |
|
|||||
|
2017
Q1 | $190M | Buy |
|
|||||
|
2016
Q4 | $138M | Sell |
|
|||||
|
2016
Q3 | $253M | Buy |
|
|||||
|
2016
Q2 | $169M | Buy |
|
|||||
|
2016
Q1 | $130M | Sell |
|
|||||
|
2015
Q4 | $260M | Buy |
|
|||||
|
2015
Q3 | $179M | Sell |
|
|||||
|
2015
Q2 | $257M | Buy |
|
|||||
|
2015
Q1 | $89.8M | Sell |
|
|||||
|
2014
Q4 | $104M | Sell |
|
|||||
|
2014
Q3 | $113M | Sell |
|
|||||
|
2014
Q2 | $134M | Sell |
|
|||||
|
2014
Q1 | $165M | Buy |
|
|||||
|
2013
Q4 | $143M | Sell |
|
|||||
|
2013
Q3 | $128M | Sell |
|
|||||
|
2013
Q2 | $121M | Buy |
|